U.S. flag

An official website of the United States government

NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg) AND Kufor-Rakeb syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
May 4, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000001280.6

Allele description [Variation Report for NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)]

NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)

Gene:
ATP13A2:ATPase cation transporting 13A2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)
HGVS:
  • NC_000001.11:g.16996008C>G
  • NG_009054.1:g.20921G>C
  • NM_001141973.3:c.1495G>C
  • NM_001141974.3:c.1495G>C
  • NM_022089.4:c.1510G>CMANE SELECT
  • NP_001135445.1:p.Gly499Arg
  • NP_001135446.1:p.Gly499Arg
  • NP_071372.1:p.Gly504Arg
  • LRG_834t1:c.1510G>C
  • LRG_834:g.20921G>C
  • LRG_834p1:p.Gly504Arg
  • NC_000001.10:g.17322503C>G
  • Q9NQ11:p.Gly504Arg
Protein change:
G499R; GLY504ARG
Links:
UniProtKB: Q9NQ11#VAR_058455; OMIM: 610513.0004; dbSNP: rs121918227
NCBI 1000 Genomes Browser:
rs121918227
Molecular consequence:
  • NM_001141973.3:c.1495G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001141974.3:c.1495G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022089.4:c.1510G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Kufor-Rakeb syndrome (KRS)
Synonyms:
Park 9; Pallidopyramidal degeneration with supranuclear upgaze paresis, and dementia; PARKINSON DISEASE 9, AUTOSOMAL RECESSIVE, JUVENILE-ONSET
Identifiers:
MONDO: MONDO:0011706; MedGen: C1847640; Orphanet: 306674; Orphanet: 314632; OMIM: 606693

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000021430OMIM
no assertion criteria provided
Pathogenic
(May 8, 2007)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002518548Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2019)
Pathogenic
(May 4, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Di Fonzo A, Chien HF, Socal M, Giraudo S, Tassorelli C, Iliceto G, Fabbrini G, Marconi R, Fincati E, Abbruzzese G, Marini P, Squitieri F, Horstink MW, Montagna P, Libera AD, Stocchi F, Goldwurm S, Ferreira JJ, Meco G, Martignoni E, Lopiano L, Jardim LB, et al.

Neurology. 2007 May 8;68(19):1557-62.

PubMed [citation]
PMID:
17485642

Details of each submission

From OMIM, SCV000021430.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a Brazilian man with Kufor-Rakeb syndrome (KRS; 606693), Di Fonzo et al. (2007) identified a homozygous 1510G-C transversion in exon 15 of the ATP13A2 gene, resulting in a gly504-to-arg (G504R) substitution in the larger cytosolic loop close to the predicted catalytic phosphorylation site. The unaffected parents were heterozygous for the mutation, which was not found in 654 control chromosomes. The patient was diagnosed with levodopa-responsive parkinsonism at age 12 years. On examination at the age of 18, he had severe akinetic-rigid parkinsonism with episodic levodopa-induced choreic dyskinesias, visual hallucinations, and aggressive behaviors. However, his mental status remained good, and he was cognitively intact between episodes. Other features included supranuclear vertical gaze paresis, diffuse cerebral atrophy, and lip/chin tremor. He did not have myoclonus or tremor in the limbs. Di Fonzo et al. (2007) postulated that the missense mutation may have resulted in a milder phenotype than that reported for frameshift or truncating mutations.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Mendelics, SCV002518548.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024